By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Matinas BioPharma 

915 Klosterman Road East

Tarpon Springs  Florida  34689  U.S.A.
Phone: 1-908-443-1860 Fax: n/a


Company News
Matinas BioPharma Announces Interim Data From NIH-Conducted Phase IIa Clinical Study Of Orally-Administered MAT2203 For The Treatment Of Chronic Refractory Mucocutaneous Candidiasis 6/5/2017 12:44:35 PM
Matinas BioPharma Reports 2017 First Quarter Financial Results And Provides Corporate Update 5/16/2017 11:10:22 AM
Matinas BioPharma Presents Positive Preclinical Data Of Orally Available DNA Vaccines At The 27th Annual European Congress Of Clinical Microbiology And Infectious Diseases 4/24/2017 11:02:36 AM
Matinas BioPharma Appoints Dominick Dipaolo As Senior Vice President Of Quality And Regulatory Compliance 4/18/2017 11:15:23 AM
Matinas BioPharma Appoints Eric J. Ende, M.B.A, M.D. To Its Board Of Directors 3/30/2017 11:17:28 AM
Matinas BioPharma To Host Fiscal Year 2016 Update Conference Call 3/29/2017 11:10:47 AM
Matinas BioPharma To Ring NYSE Closing Bell On March 29th, 2017 3/28/2017 11:25:00 AM
Matinas BioPharma Reports Positive Topline Data From Phase I Study Of MAT2501 3/27/2017 7:16:33 AM
Matinas BioPharma's Weak Drug Pipeline And Investors With Fraudulent Histories 3/27/2017 6:33:27 AM
Matinas BioPharma Announces Positive Preclinical Efficacy Results Of MAT2501 In An In Vitro Model Of Mycobacterium Abscessus Infection 3/8/2017 8:51:17 AM